(iv) NODDI imaging acquired in the single setting of MRI would add value in assessing the possible etiology (CVD vs. tau related changes vs. possibly TDP-43 in the absence of amyloid and tau) and their corresponding contribution to cognitive performance. The gene discussed is MAPT; the disease is amyloidosis.